N-Methyl-D-Aspartate (NMDA) Receptors: Therapeutic Target against Cancer
<p>Glutamate mainly acts as an excitatory neurotransmitter in the central nervous system controlling variety of neuro-physiological functions like synaptic signaling, learning, memory, etc. However, uncontrolled or excessive production of glutamate is neurotoxic and can damage neurons by over...
Saved in:
Main Authors: | Raj Kumar Koiri (Author), Aditi Mehrotra (Author) |
---|---|
Format: | Book |
Published: |
International Journal of Immunotherapy and Cancer Research - Peertechz Publications,
2015-09-03.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Direct Inhibition of N-Methyl-D-Aspartate (NMDA)-Receptor Function by Antiglaucomatous β-Antagonists
by: Tatsuo Nagata, et al.
Published: (2008) -
Discovery of GluN2A subtype-selective N-methyl-d-aspartate (NMDA) receptor ligands
by: Liyang Jiang, et al.
Published: (2024) -
Molecular Docking of Active Compound of Lavandula angustifolia Mill Essential Oil against N-methyl-D-aspartate (NMDA) Receptor
by: Baiq Risky Wahyu Lisnasari, et al.
Published: (2022) -
Anti-N-Methyl-D-Aspartate Receptor Encephalitis
by: J Gordon Millichap
Published: (2013) -
Anti-N-Methyl-d-Aspartate Receptor Encephalitis
by: Te-Yu Hung, et al.
Published: (2011)